Phase II Placebo-Controlled Study of 4-Aminosalicylic Acid for Ulcerative Colitis
2 other identifiers
interventional
30
0 countries
N/A
Brief Summary
OBJECTIVES: I. Assess the safety and efficacy of 4-aminosalicylic acid in patients with mildly to moderately severe ulcerative colitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 1996
CompletedFirst Submitted
Initial submission to the registry
February 24, 2000
CompletedFirst Posted
Study publicly available on registry
February 25, 2000
CompletedJune 24, 2005
December 1, 2001
February 24, 2000
June 23, 2005
Conditions
Keywords
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Related Publications (1)
Beeken W, Howard D, Bigelow J, Trainer T, Roy M, Thayer W, Wild G. Controlled trial of 4-ASA in ulcerative colitis. Dig Dis Sci. 1997 Feb;42(2):354-8. doi: 10.1023/a:1018874120749.
PMID: 9052519BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Warren L. Beeken
University of Vermont
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Sponsor Type
- NIH
Study Record Dates
First Submitted
February 24, 2000
First Posted
February 25, 2000
Study Start
June 1, 1996
Last Updated
June 24, 2005
Record last verified: 2001-12